A Study of TNM001 in Chinese Healthy Preterm and Term Infants

Clinical trial NCT05630573 · COMPLETED

Trial details

NCT number: NCT05630573
Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2022-10-25
Primary completion: 2023-06-30
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.